Kezdőlap › Akut mieloid leukémia › Kalifornia › Baldwin Park
Akut mieloid leukémia klinikai vizsgálatok: Baldwin Park, CA
40 Akut mieloid leukémia vizsgálat keres résztvevőket Baldwin Park és környéke (kb. 30 mérföldes körzetben) helyszínein. Nyissa meg a vizsgálatot, hogy lássa, ki csatlakozhat, és hogyan léphet kapcsolatba a csapattal.
Hivatalos vizsgálati szöveg (angol)
Vizsgálatra keres résztvevőket? Emelje ki az oldal tetején — $99 / 30 nap →
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Toborzás folyamatban2/3. fázis
- City of Hope National Medical Center /ID# 279568, Duarte · 4 mérföldre
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Toborzás folyamatban1. fázis
- City of Hope, Duarte · 4 mérföldre
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Toborzás folyamatban1. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Toborzás folyamatban3. fázis
- Clinical Trial Site, Duarte · 4 mérföldre
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Toborzás folyamatban3. fázis
- City of Hope, Duarte · 4 mérföldre
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Toborzás folyamatban3. fázis
- City of Hope Comprehensive Cancer Center, Duarte · 4 mérföldre
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Toborzás folyamatban2. fázis
- City of Hope Comprehensive Cancer Center, Duarte · 4 mérföldre
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Toborzás folyamatban1. fázis
- City of Hope National Medical Center, Duarte · 4 mérföldre
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Toborzás folyamatban1/2. fázisEgészséges önkéntesek is jelentkezhetnek
- City of Hope, Duarte · 4 mérföldre
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Toborzás folyamatban1/2. fázis
- City of Hope Comprehensive Cancer Center, Duarte · 4 mérföldre
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Toborzás folyamatban1/2. fázis
- City of Hope National Medical Center, Duarte · 4 mérföldre
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Toborzás folyamatban1. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Toborzás folyamatban1. fázis
- City of Hope, Duarte · 4 mérföldre
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
Toborzás folyamatban1. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
Individualized AML Treatment
Toborzás folyamatbanMegfigyeléses tanulmány
- City of Hope Medical Center, Duarte · 4 mérföldre
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Toborzás folyamatban2. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Toborzás folyamatban1. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Toborzás folyamatban1. fázisEgészséges önkéntesek is jelentkezhetnek
- City of Hope Medical Center, Duarte · 4 mérföldre
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Toborzás folyamatban3. fázis
- City of Hope Comprehensive Cancer Center - Duarte, Duarte · 4 mérföldre
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
Toborzás folyamatban1. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Toborzás folyamatbanMegfigyeléses tanulmány
- City of Hope, Duarte · 4 mérföldre
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Toborzás folyamatban1. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Toborzás folyamatban2. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
A Study of Revumenib and Mezigdomide in People With Leukemia
Toborzás folyamatban1/2. fázis
- City of Hope Cancer Center (Data collection only), Duarte · 4 mérföldre
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Toborzás folyamatban1. fázis
- City of Hope, Duarte · 4 mérföldre
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Toborzás folyamatban1. fázisEgészséges önkéntesek is jelentkezhetnek
- City of Hope Medical Center, Duarte · 4 mérföldre
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Toborzás folyamatban1. fázis
- City of Hope, Duarte · 4 mérföldre
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Toborzás folyamatban1. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Toborzás folyamatban2. fázis
- City of Hope, Duarte · 4 mérföldre
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Toborzás folyamatban1. fázis
- City of Hope, Duarte · 4 mérföldre
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Toborzás folyamatban2. fázisEgészséges önkéntesek is jelentkezhetnek
- City of Hope Medical Center, Duarte · 4 mérföldre
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Toborzás folyamatban1. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
Toborzás folyamatban1. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Toborzás folyamatban1. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Toborzás folyamatban1. fázis
- City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4 mérföldre
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Toborzás folyamatban2. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
Toborzás folyamatban1. fázis
- City of Hope - Duarte, Duarte · 4 mérföldre
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Toborzás folyamatban1. fázis
- City of Hope Medical Center, Duarte · 4 mérföldre
Study of REM-422 in Patients With AML or Higher Risk MDS
Toborzás folyamatban1. fázis
- City of Hope, Duarte · 4 mérföldre
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Toborzás folyamatban1. fázis
- City of Hope National Medical Center, Duarte · 4 mérföldre
Akut mieloid leukémia vizsgálatok más városokban
- Houston, TX85 tanulmány
- New York City, NY51 tanulmány
- Boston, MA44 tanulmány
- Seattle, WA41 tanulmány
- Columbus, OH35 tanulmány
- Philadelphia, PA34 tanulmány
- Durham, NC33 tanulmány
- Atlanta, GA31 tanulmány
- Tampa, FL29 tanulmány
- Chicago, IL26 tanulmány
- Portland, OR25 tanulmány
- Washington, DC24 tanulmány
Egyéb vizsgálatok: Baldwin Park
- Mellrák44 tanulmány
- Kolorektális rák37 tanulmány
- Nem kis sejtes tüdőrák36 tanulmány
- Rák (minden típus)34 tanulmány
- Prosztatarák30 tanulmány
- Áttétes rák30 tanulmány
- Myelodysplasticus szindrómák26 tanulmány
- Petefészekrák25 tanulmány
- Tüdőrák24 tanulmány
- Multiplex mielóma23 tanulmány
- Gyomorrák22 tanulmány
- Akut limfoblasztos leukémia21 tanulmány
Forrás: ClinicalTrials.gov, adatok lekérve: 2026. okt. 6.. Minden vizsgálat saját alkalmassági feltételeket határoz meg; a döntést a vizsgálati csapat hozza meg.